P. Lähteenmäki

发表

Clinical trial with Nestorone subdermal contraceptive implants.

H. Croxatto, S. Díaz, M. Pavez, 1995, Contraception.

Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.

D. Mishell, I. Sivin, H. Croxatto, 2005, Contraception.

Subdermal progestin implant (Nestorone®) in the treatment of endometriosis: clinical response to various doses

A. Moo-Young, P. Lähteenmäki, Kaija Ylänen, 2003, Acta obstetricia et gynecologica Scandinavica.

Milk and plasma concentrations of the progestin ST-1435 in women treated parenterally with ST-1435.

H. Croxatto, S. Díaz, P. Lähteenmäki, 1990, Contraception.

Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.

J. Puolakka, J. Suvisaari, P. Lähteenmäki, 1998, BMJ.

Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device.

P. Lähteenmäki, H. Kurunmäki, J. Toivonen, 1984, Contraception.

The levonorgestrel intrauterine system in contraception

T. Backman, I. Rauramo, P. Lähteenmäki, 2000, Steroids.

Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.

H. Croxatto, P. Lähteenmäki, A. Salvatierra, 1996, Contraception.

Pharmacokinetics and metabolism of RU 486.

H. Croxatto, D. Shoupe, O. Heikinheimo, 1987, Journal of steroid biochemistry.

Squirrel monkey corticosteroid-binding globulin: primary structure and comparison with the human protein.

G. Hammond, P. Siiteri, J. Murai, 1994, Endocrinology.

Distribution and percentages of non-protein bound contraceptive steroids in human serum.

G. Hammond, P. Lähteenmäki, T. Luukkainen, 1982, Journal of steroid biochemistry.

A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities.

G. Hammond, P. Lähteenmäki, P. Lähteenmäki, 1983, Clinica chimica acta; international journal of clinical chemistry.

Alterations in the pituitary-thyroid and pituitary-adrenal axes--consequences of long-term mifepristone treatment.

S. Grunberg, O. Heikinheimo, S. Ranta, 1997, Metabolism: clinical and experimental.

Sustained-release subdermal estradiol implants: a new alternative in estrogen replacement therapy.

S. Suhonen, P. Lähteenmäki, H. Allonen, 1993, American journal of obstetrics and gynecology.

Endometrial effect of transdermal estradiol and progestin ST-1435 in postmenopausal women.

S. Suhonen, P. Lähteenmäki, M. Haukkamaa, 1992, Fertility and sterility.

Cholesterol-lowering effect of spreads enriched with microcrystalline plant sterols in hypercholesterolemic subjects

J. Yliruusi, R. Hiltunen, T. Seppänen-Laakso, 2001, European journal of nutrition.

Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men.

J. Suvisaari, S. I. Saleh, A. Moo-Young, 1999, Contraception.

Pharmacokinetics of mifepristone after low oral doses.

O. Heikinheimo, P. Lähteenmäki, R. Kekkonen, 1996, Contraception.

Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men.

J. Suvisaari, H. Croxatto, K. Sundaram, 1999, Human reproduction.

Haemodynamic and hormonal effects of short-term oestradiol treatment in postmenopausal women.

P. Lähteenmäki, T. Pyörälä, H. Luotola, 1979, Maturitas.

Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy.

S. Suhonen, P. Lähteenmäki, T. Holmström, 1995, Fertility and sterility.

Sustained-release estradiol implants and a levonorgestrel-releasing intrauterine device in hormone replacement therapy.

S. Suhonen, P. Lähteenmäki, H. Allonen, 1995, American journal of obstetrics and gynecology.

Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.

S. Suhonen, P. Lähteenmäki, H. Laine, 1993, Maturitas.

Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.

J. Tuominen, P. Lähteenmäki, T. Luukkainen, 1993, Fertility and sterility.

Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.

H. Alfthan, O. Heikinheimo, P. Lähteenmäki, 1990, Fertility and sterility.

Late postcoital treatment against pregnancy with antiprogesterone RU 486.

H. Alfthan, O. Ylikorkala, P. Lähteenmäki, 1988, Fertility and sterility.

Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.

O. Heikinheimo, P. Lähteenmäki, T. Luukkainen, 1988, Fertility and sterility.

The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone‐binding globulin, insulin and insulin‐like growth factor binding protein‐1

P. Lähteenmäki, E. Rutanen, P. Pakarinen, 1999, Acta obstetricia et gynecologica Scandinavica.

Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.

K. Kontula, H. Croxatto, O. Heikinheimo, 1987, Journal of steroid biochemistry.

Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.

J. Suvisaari, P. Lähteenmäki, 1996, Contraception.

Postabortal contraception.

P. Lähteenmäki, Pekka Lähteenmäki, 1993, Annals of medicine.

Antiprogesterone RU 486--a drug for non-surgical abortion.

O. Heikinheimo, O. Ylikorkala, P. Lähteenmäki, 1990, Annals of medicine.

Comparison of Performances of Two Commercially Available Tests, a PCR Assay and a Ligase Chain Reaction Test, in Detection of Urogenital Chlamydia trachomatis Infection

M. Lehtinen, T. Reunala, J. Paavonen, 1998, Journal of Clinical Microbiology.

First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.

D. Mishell, I. Sivin, V. Brache, 1997, Contraception.

Vaginal epithelial surface appearances in women using vaginal rings for contraception.

I. Fraser, D. Mishell, V. Brache, 2000, Contraception.

Influence of Oral Contraceptives on Immediate Postabortal Pituitary‐Ovarian Function

P. Lähteenmäki, 1978, Acta obstetricia et gynecologica Scandinavica. Supplement.

Novel delivery systems in contraception.

H. Jukarainen, P. Lähteenmäki, 2000, British medical bulletin.

Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men.

J. Suvisaari, C. Bardin, K. Sundaram, 1997, Human reproduction.

The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestin action.

O. Heikinheimo, Oskari Heikinheimo, Raimo Kekkonen, 2003, Contraception.

Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography.

H. Croxatto, D. Shoupe, O. Heikinheimo, 1986, Contraception.

Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.

S. Suhonen, O. Heikinheimo, P. Lähteenmäki, 2015, Human reproduction.

Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.

M. Gissler, S. Suhonen, O. Heikinheimo, 2012, Human reproduction.

Fertility control Intrauterine contraception : incidence and factors associated with uterine perforation — a population-based study

M. Gissler, S. Suhonen, O. Heikinheimo, 2012 .

Lynestrenol induced therapeutic amenorrhea: Effects of dose reduction on serum sex‐hormones and lipids

M. Tikkanen, P. Lähteenmäki, K. Huovinen, 1992, Acta obstetricia et gynecologica Scandinavica.

Predicting Painful or Difficult Intrauterine Device Insertion in Nulligravid Women

S. Suhonen, O. Heikinheimo, P. Lähteenmäki, 2014, Obstetrics and gynecology.

Three‐year follow‐up of the use of a levonorgestrel‐releasing intrauterine system in hormone replacement therapy

S. Suhonen, P. Lähteenmäki, Teddy Holmström, 1997, Acta obstetricia et gynecologica Scandinavica.

Distribution of RU 486 and its demethylated metabolites in humans.

O. Heikinheimo, P. Lähteenmäki, M. Haukkamaa, 1989, The Journal of clinical endocrinology and metabolism.

Uterine perforation caused by intrauterine devices: clinical course and treatment.

M. Gissler, S. Suhonen, O. Heikinheimo, 2013, Human reproduction.

Levonorgestrel plasma concentrations and hormone profiles after 1 year of treatment with a levonorgestrel-IUD.

P. Lähteenmäki, T. Luukkainen, C. Nilsson, 1980 .

The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.

E. Lehtonen, P. Lähteenmäki, I. Reima, 1998, Human reproduction.

Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium.

P. Lähteenmäki, M. Haukkamaa, E. Rutanen, 1992, The Journal of clinical endocrinology and metabolism.

Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium.

S. Suhonen, P. Lähteenmäki, M. Haukkamaa, 1996, Fertility and sterility.

Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women.

I. Fraser, M. Hickey, D. Mishell, 1999, Human reproduction.

Contraception and HIV infection in women

O. Heikinheimo, P. Lähteenmäki, 2008, Human reproduction update.

Progestin-only contraceptive rings

D. Mishell, A. Faúndes, V. Brache, 2000, Steroids.

Effect of mifepristone on inhibition of ovulation and induction of luteolysis.

C. Bardin, H. Croxatto, O. Heikinheimo, 1994, Human reproduction.

Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants.

D. Mishell, I. Sivin, P. Darney, 1997, Contraception.

Hepatic metabolism and distribution of mifepristone and its metabolites in rats.

R. Huupponen, M. Koulu, U. Pesonen, 1994, Human reproduction.

Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation?

K. Gordon, O. Heikinheimo, S. Ranta, 1999, Human reproduction.

The Levonorgestrel-Releasing IUD

P. Lähteenmäki, J. Toivonen, T. Luukkainen, 1988 .

Charcoal treatment and risk of escape ovulation in oral contraceptive users.

J. Tuominen, S. Ranta, P. Lähteenmäki, 2001, Human reproduction.

The possible role of enterohepatic cycling on bioavailability of norethisterone and gestodene in women using combined oral contraceptives.

J. Tuominen, S. Ranta, P. Lähteenmäki, 2001, Contraception.

Pharmacokinetics of 7α‐Methyl‐19‐nortestosterone in Men and Cynomolgus Monkeys

J. Suvisaari, C. Bardin, K. Sundaram, 1997, Journal of Andrology.

Immediate postabortal contraception with a microdose combined preparation: gonadotropin, estradiol and progesterone levels during the last treatment cycle and after discontinuation of oral contraceptives.

P. Lähteenmäki, 1978, Contraception.

Suppression of ovarian function with the transdermally given synthetic progestin ST 1435

P. Lähteenmäki, M. Haukkamaa, M. Laurikka-Routti, 1992 .

Concentration-dependent mechanisms of ovulation inhibition by the progestin ST-1435.

P. Lähteenmäki, 1985, Fertility and sterility.

Effect of RU 486 on the Pituitary-Adrenal Axis in the Dog

D. Krieger, C. Wade, C. Bardin, 1985 .

Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial

B. Friedland, G. Ramjee, N. Morar, 2015, AIDS and Behavior.

Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.

I. Fraser, D. Phillips, D. Mishell, 1997, Contraception.

Intracervical release of levonorgestrel for contraception.

P. Lähteenmäki, H. Kurunmäki, J. Toivonen, 1981, Contraception.

Intestinal absorption of ST-1435 in rats.

P. Lähteenmäki, 1984, Contraception.

Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.

J. Deprest, I. Brosens, J. Tuominen, 1998, American journal of obstetrics and gynecology.

Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.

P. Lähteenmäki, K. Elomaa, 1999, Contraception.

Intracervical release of ST-1435 for contraception.

P. Lähteenmäki, H. Kurunmäki, J. Toivonen, 1984, Contraception.

A 12-month comparative clinical investigation of a levonorgestrel-releasing intracervical device situated in the uterine cavity or cervical canal.

J. Tuominen, P. Lähteenmäki, K. Elomaa, 1996, Contraception.

Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules.

P. Lähteenmäki, H. Kurunmäki, J. Toivonen, 1985, Contraception.

Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.

P. Lähteenmäki, H. Kurunmäki, J. Toivonen, 1984, Contraception.

Postabortal contraception with norethisterone enanthate injections.

P. Lähteenmäki, J. Toivonen, 1983, Contraception.

The progestin ST 1435--rapid metabolism in man.

O. Heikinheimo, P. Lähteenmäki, M. Haukkamaa, 1994, Contraception.

Selection and performance of the levonorgestrel-releasing intrauterine system.

C. Bardin, M. Venhola, J. Tuominen, 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

Plasma concentrations of ethinylestradiol and D-norgestrel during two immediate postabortal oral contraceptive cycles.

P. Lähteenmäki, C. Nilsson, 1978, Contraception.

Direct intraperitoneal or intrauterine insemination and superovulation in infertility treatment: a randomized study.

O. Hovatta, A. Koskimies, P. Lähteenmäki, 1990, Fertility and sterility.

FERTILISATION IN WOMEN WITH INTRAUTERINE DEVICES

P. Lähteenmäki, C. Nilsson, 1977, The Lancet.

Recovery of ovarian function after the use of a d-norgestrel-releasing IUD.

P. Lähteenmäki, C. Nilsson, 1977, Contraception.

Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.

P. Lähteenmäki, M. Haukkamaa, M. Laurikka-Routti, 1993, Fertility and sterility.

Intrauterine Hormone-Releasing Systems

P. Lähteenmäki, 1999 .

Management of menorrhagia

P. Lähteenmäki, 1990, BMJ.

Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU 486.

U. Turpeinen, O. Heikinheimo, O. Ylikorkala, 1990, Acta endocrinologica.

Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.

P. Lähteenmäki, C. Nilsson, 1978, Annals of clinical research.

The levonorgestrel-releasing intrauterine device.

P. Lähteenmäki, J. Toivonen, T. Luukkainen, 1990, Advances in contraceptive delivery systems : CDS.

RETURN OF OVARIAN FUNCTION AFTER ABORTION

P. Lähteenmäki, T. Luukkainen, P. Lähteenmäki, 1978, Clinical endocrinology.

The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation.

P. Lähteenmäki, T. Luukkainen, H. Laine, 1995, Human reproduction.

Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.

P. Lähteenmäki, T. Luukkainen, C. Nilsson, 1980, Contraception.

Five years' experience with levonorgestrel-releasing IUDs.

P. Lähteenmäki, J. Toivonen, T. Luukkainen, 1986, Contraception.

Outpatient Therapeutic Abortion With Mifepristone

H. Alfthan, O. Ylikorkala, P. Lähteenmäki, 1989, Obstetrics and gynecology.

Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.

J. Suvisaari, P. Lähteenmäki, T. Luukkainen, 1997, Fertility and sterility.

Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.

M. Gissler, S. Suhonen, O. Heikinheimo, 2012, Human reproduction.